Journal ArticleDOI
Functionalization of mesoporous MCM-41 for the delivery of curcumin as an anti-inflammatory therapy
TLDR
In this article , mesoporous silica nanoparticles (MSNs) composed of MCM-41 were synthesized and modified with amine groups (i.e., NH2) to form NH2/MCM- 41, which was loaded with curcumin (CUR) to create an efficient carriers in drug delivery systems (DDSs).About:
This article is published in Advanced Powder Technology.The article was published on 2022-01-01. It has received 40 citations till now. The article focuses on the topics: Thermogravimetric analysis & MCM-41.read more
Citations
More filters
Journal ArticleDOI
Interaction behavior of curcumin encapsulated onto functionalized SBA-15 as an efficient carrier and release in drug delivery
TL;DR: In this paper , a mesoporous silica SBA-15 was prepared and functionalized with amine groups (i.e., NH 2 ) to form NH 2 /SBA15.
Journal ArticleDOI
Degradation of methylene blue through Fenton-like reaction catalyzed by MoS2-doped sodium alginate/Fe hydrogel.
TL;DR: In this paper , a low-cost and high-performance MoS2/sodium alginate (SA)/Fe (MSF) hydrogel catalyst was prepared to catalyze the degradation of methylene blue (MB) through the Fenton reaction without the addition of Fe2+.
Journal ArticleDOI
Removal of sulfur compounds from real diesel fuel employing the encapsulated mesoporous material adsorbent Co/MCM-41 in a fixed-bed column
TL;DR: In this article , the authors used the Thomas and Yoon-Nelson models to anticipate the breakthrough curves (BTC) and compute the usual laboratory continuous adsorption characteristics required for the best design of this process.
Journal ArticleDOI
Photocatalytic degradation of cefotaxime pharmaceutical compounds onto a modified nanocatalyst
Noor. S. Abbood,Nisreen Sabti Mohammed Ali,Eman H. Khader,Hasan Sh. Majdi,Talib M. Albayati,Noori M. Cata Saady +5 more
Journal ArticleDOI
Recent Trends in Drug Delivery and Emerging Biomedical Applications of Gelatin for Ophthalmic Indications
TL;DR: Micro and nano gelatin-based fabrications, namely hydrogels, nanoparticles, nanocomposites, microspheres, scaffolds, and ocular adhesives, are extensively studied and recent advances expediting these delivery systems with biomedical applications have been systematically presented.
References
More filters
Journal ArticleDOI
Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores
Dongyuan Zhao,Jianglin Feng,Qisheng Huo,Nicholas A. Melosh,Glenn H. Fredrickson,Bradley F. Chmelka,Galen D. Stucky +6 more
TL;DR: Use of amphiphilic triblock copolymers to direct the organization of polymerizing silica species has resulted in the preparation of well-ordered hexagonal mesoporous silica structures (SBA-15) with uniform pore sizes up to approximately 300 angstroms.
Journal ArticleDOI
Targeting of porous hybrid silica nanoparticles to cancer cells.
Jessica M. Rosenholm,Annika Meinander,Annika Meinander,Emilia Peuhu,Rasmus Niemi,John E. Eriksson,Cecilia Sahlgren,Mika Lindén +7 more
TL;DR: The biospecifically tagged hybrid PEI-silica particles were shown to be noncytotoxic and able to specifically target folate receptor-expressing cancer cells also under coculture conditions.
Journal ArticleDOI
pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery
TL;DR: In this article, an efficient pH-responsive carrier system has been constructed by oppositely charged ionic interaction between carboxylic acid modified SBA-15 silica rods and polyelectrolyte.
Journal ArticleDOI
Equilibrium and kinetic studies of methyl orange adsorption on multiwalled carbon nanotubes
TL;DR: In this paper, the adsorption of methyl orange onto multiwalled carbon nanotubes (MWCNTs) from aqueous solutions was studied, in which the influence of contact time, dosage, temperature, pH, and methyl orange concentration in the solution were investigated.
Journal ArticleDOI
Bioavailability of quercetin: problems and promises.
TL;DR: Enhanced bioavailability of QC in the near future is likely to bring this product to the forefront of therapeutic agents for treatment of human disease.